Patent application number | Description | Published |
20110190490 | OXAZOLOPYRIMIDINES AS EDG-1 RECEPTOR AGONISTS - The present invention relates to oxazolopyrimidine compounds of the formula I in which A, R | 08-04-2011 |
20130023544 | CARBOXYLIC ACID DERIVATIVES HAVING AN OXAZOLO[5,4-d]PYRIMIDINE RING - The invention therefore relates to compounds of the formula I | 01-24-2013 |
20130023545 | CYCLOALKYLOXYCARBOXYLIC ACID DERIVATIVES - The present invention relates to cycloalkyloxycarboxylic acid derivatives of the formula I | 01-24-2013 |
20130023557 | CARBOXYLIC ACID DERIVATIVES HAVING AN OXAZOLO[5,4-B]PYRIDINE RING - The invention therefore relates to compounds of the formula I | 01-24-2013 |
20130023558 | CARBOXYLIC ACID DERIVATIVES HAVING AN OXAZOLO[4,5-c]PYRIDINE RING - Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring | 01-24-2013 |
20130030008 | ACYLAMINO-SUBSTITUTED FUSED CYCLOPENTANECARBOXYLIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS - The present invention relates to compounds of the formula I, | 01-31-2013 |
20130072501 | 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE DERIVATIVES - The invention relates to oxazolopyrimidine compounds of formula I, where A, R | 03-21-2013 |
20130072502 | HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES HAVING A 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING - Heterocyclic carboxylic acid derivatives comprising a 2,5-substituted oxazolopyrimidine ring as Edg-1 receptor agonists | 03-21-2013 |
20130079357 | CARBOXYLIC ACID DERIVATIVES HAVING A 2,5,7-SUBSTITUTED OXAZOLOPYRIMIDINE RING - The invention relates to oxazolopyrimidine compounds of formula (I), where A, R | 03-28-2013 |
20130079358 | CARBOXYLIC ACID DERIVATIVES HAVING A 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING - The present invention relates to oxazolopyrimidine compounds of the formula I, | 03-28-2013 |
20130123143 | METHOD FOR IDENTIFYING A COMPOUND HAVING AN ANTIARRHYTHMIC EFFECT AS WELL AS USES RELATING THERETO - The present invention relates to a method of identifying a compound having an antiarrhythmic effect and to a use of adenosine-diphospho-ribose cyclase (cardiac ADPRC) for the identification of a compound having said effect. | 05-16-2013 |
20130137685 | 2,5,7-SUBSTITUTED OXAZOLOPYRIMIDINE DERIVATIVES - The invention relates to oxazolopyrimidine compounds of formula (I), where A, R | 05-30-2013 |
20130158051 | HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES HAVING A 2,5,7-SUBSTITUTED OXAZOLOPYRIMIDINE RING - The invention relates to oxazolopyrimidine compounds of formula (I), where A, R | 06-20-2013 |
20130225605 | ACYLAMINO-SUBSTITUTED FUSED CYCLOPENTANECARBOXYLIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS - The present invention relates to compounds of the formula I, | 08-29-2013 |
20140099333 | PYRROLIDINONE DERIVATIVES AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS - The present invention relates to pyrrolidinone derivatives. The pyrrolidinone derivatives are GPR119 modulators and useful for the prevention and/or treatment of diabetes, obesity, dyslipidemia and related disorders. The invention furthermore relates to the use of pyrrolidinone derivatives as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them. | 04-10-2014 |
20140221656 | CRYSTALLINE SOLVATES OF 6-(PIPERIDIN-4-YLOXY)-2H-ISOQUINOLIN-1-ONE HYDROCHLORIDE - The present invention relates to crystalline solvates of 6-(Piperidin-4-yloxy)-2H-isoquinolin-1-one hydrochloride, processes for their preparation and the use thereof. | 08-07-2014 |
20140309264 | ACYLAMINO-SUBSTITUTED FUSED CYCLOPENTANECARBOXYLIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS - The present invention relates to compounds of the formula I, | 10-16-2014 |